Remus Pharmaceuticals Ltd vs Sigachi Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Remus Pharmaceuticals Ltd is ₹ 705.75 as of 05 May 15:30 . The P/E Ratio of Remus Pharmaceuticals Ltd changed from 49.4 on March 2024 to 45.4 on March 2025 . This represents a CAGR of -4.13% over 2 yearsThe P/E Ratio of Sigachi Industries Ltd changed from 22.2 on March 2022 to 19.3 on March 2025 . This represents a CAGR of -3.44% over 4 years The Market Cap of Remus Pharmaceuticals Ltd changed from ₹ 1016 crore on March 2024 to ₹ 1319 crore on March 2025 . This represents a CAGR of 13.93% over 2 yearsThe Market Cap of Sigachi Industries Ltd changed from ₹ 888.92 crore on March 2022 to ₹ 1342 crore on March 2025 . This represents a CAGR of 10.85% over 4 years The revenue of Remus Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sigachi Industries Ltd for the Dec '25 is ₹ 117.68 crore as compare to the Sep '25 revenue of ₹ 117.63 crore. This represent the growth of 0.04% The ebitda of Remus Pharmaceuticals Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sigachi Industries Ltd for the Dec '25 is ₹ 5.45 crore as compare to the Sep '25 ebitda of ₹ 14.67 crore. This represent the decline of -62.85% The net profit of Remus Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Sigachi Industries Ltd changed from ₹ 12.76 crore to ₹ -0.02 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Remus Pharmaceuticals Ltd changed from 2.56 % on March 2023 to 4.44 % on March 2025 . This represents a CAGR of 20.15% over 3 yearsThe Dividend Payout of Sigachi Industries Ltd changed from 8.08 % on March 2022 to 8.02 % on March 2025 . This represents a CAGR of -0.19% over 4 years .

About Remus Pharmaceuticals Ltd

Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

About Sigachi Industries Ltd

Sigachi Industries Limited was originally incorporated as 'Sigachi Chloro-Chemicals Private Limited' on 11 January, 1989.
To diversify the business activities, the name of Company was changed to 'Sigachi Industries Private Limited' on 29 March, 2012.
Subsequently, it was converted from a Private Limited to a Public Limited and the name was changed to 'Sigachi Industries Limited' on 19 December, 2019. The Company is is one of the major producer and distributor of Micro Crystalline Cellulose Powder(MCCP).
The Company currently offers 59 distinct grades of MCC through its two state-of-the-art manufacturing facilities in Hyderabad and Gujarat, with a total installed capacity of 11,880 MTPY. Apart from these, it is an industry leader in the field of Pharma Excipients, Nutra and food ingredients.

FAQs for the comparison of Remus Pharmaceuticals Ltd and Sigachi Industries Ltd

Which company has a larger market capitalization, Remus Pharmaceuticals Ltd or Sigachi Industries Ltd?

Market cap of Remus Pharmaceuticals Ltd is 844 Cr while Market cap of Sigachi Industries Ltd is 773 Cr

What are the key factors driving the stock performance of Remus Pharmaceuticals Ltd and Sigachi Industries Ltd?

The stock performance of Remus Pharmaceuticals Ltd and Sigachi Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Remus Pharmaceuticals Ltd and Sigachi Industries Ltd?

As of May 5, 2026, the Remus Pharmaceuticals Ltd stock price is INR ₹716.8. On the other hand, Sigachi Industries Ltd stock price is INR ₹20.23.

How do dividend payouts of Remus Pharmaceuticals Ltd and Sigachi Industries Ltd compare?

To compare the dividend payouts of Remus Pharmaceuticals Ltd and Sigachi Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.